Metraipolis › archive › dc_c6ca92b080ad
EgLDH as a Novel Target: Design and Preliminary Efficacy Assessment of a DNA Vaccine — Europe PMC PMID:41751016
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41751016
- DOI
- 10.3390/ani16040555
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T22:19:00.132Z
- SHA-256 of the archived text
536052f6fdbc4f9657c972bd33955f86248e7198e02a1d4903fe30f27a6c1755- Stable URL of this page
https://metraipolis.com/documento/dc_c6ca92b080ad
How to cite
EgLDH as a Novel Target: Design and Preliminary Efficacy Assessment of a DNA Vaccine — Europe PMC PMID:41751016 — Europe PMC (en), https://europepmc.org/article/MED/41751016 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c6ca92b080ad (Metraipolis archive dc_c6ca92b080ad, sha256 536052f6fdbc4f9657c972bd33955f86248e7198e02a1d4903fe30f27a6c1755)
BibTeX
@misc{dcc6ca92b080ad,
title = {EgLDH as a Novel Target: Design and Preliminary Efficacy Assessment of a DNA Vaccine — Europe PMC PMID:41751016},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41751016},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c6ca92b080ad; sha256 536052f6fdbc4f9657c972bd33955f86248e7198e02a1d4903fe30f27a6c1755},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751016. Agents can read the archived copy with the MCP tool read_document.